Peifen Fu - Concepedia

Author

Peifen Fu

First Affiliated Hospital Zhejiang University ORCID

Also Known As

Chuangui Song, P Fu, P. Fu, Pei-Fen Fu, Peifen Fu, Peifen Fu (316627), Peiyi Fu

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

First Affiliated Hospital Zhejiang University Peking University Qingdao University Zhejiang University Hebei Medical University

About

Peifen Fu is an author at First Affiliated Hospital Zhejiang University specializing in medicine, breast cancer, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	178
2	Cell Biology	1	1	59
3	Immunology	1	1	59
4	Pharmacology	1	1	90
5	Cancer Genetics	1	1	29

Peifen Fu

Publications

531

Citations

H-Index

Page 1

	Year	Citations
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial Zefei Jiang, Quchang Ouyang, Tao Sun, Nature Medicine Breast OncologyMedicinePharmacologyRandomized Phase 3Breast Cancer	2024	90
Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer Peifen Fu, Minya Yao, Yu Liu, OncoTargets and Therapy	2014	82
Resveratrol promotes MICA/B expression and natural killer cell lysis of breast cancer cells by suppressing c-Myc/miR-17 pathway Jie Pan, Jiaying Shen, Wengong Si, Oncotarget	2017	72
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial Jiong Wu, Zefei Jiang, Zhenzhen Liu, BMC Medicine	2022	70
Interleukin-22 promotes triple negative breast cancer cells migration and paclitaxel resistance through JAK-STAT3/MAPKs/AKT signaling pathways Shuqian Wang, Yinan Yao, Minya Yao, Biochemical and Biophysical Research Communications CytokineJak-stat3/mapks/akt Signaling PathwaysSignaling PathwayBreast OncologyMedicine	2018	59
Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020 Jianbin Li, Haibo Wang, Cuizhi Geng, EClinicalMedicine	2020	50
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer Li Chen, Hui Li, Hao Zhang, JAMA	2024	33
EIF5A2 is a novel chemoresistance gene in breast cancer Feiya Du, Wei Chen, Minya Yao, Breast Cancer Breast OncologyBreast CancerCancer GeneticsMedicineRadiation Oncology	2014	29
Trends in Disparities and Transitions of Treatment in Patients With Early Breast Cancer in China and the US, 2011 to 2021 Jianbin Li, Jifang Zhou, Haibo Wang, JAMA Network Open	2023	26
Chinese multicentre prospective registry of breast cancer patient-reported outcome-reconstruction and oncoplastic cohort (PRO-ROC): a study protocol Lun Li, Benlong Yang, Hongyuan Li, BMJ Open	2019	20

Page 1